ACNT ASCENT INDUSTRIES CO.
Chemicals & Allied Products · Nasdaq · SEC CIK 95953 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY22.4%
TTM net income YoY-207.7%
TTM EPS YoY-211.1%
Revenue 3-yr CAGR-23.9%
Net income 3-yr CAGR—
Margins
Gross margin20.8%
Operating margin-2.7%
Net margin-1.0%
FCF margin-8.7%
EBITDA margin-1.3%
Returns
ROE-1.1%
ROA-0.8%
ROIC (approx.)-4.8%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets24.6%
Debt / equity0.00x
Current ratio4.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.48x
Accruals ratio3.7%
Payout ratio—
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $27.14M | $25.67M | $19.41M | $18.76M | $19.70M | $18.65M | $17.84M | $18.12M |
| Cost of revenue | $20.02M | $20.12M | $16.60M | $15.32M | $13.86M | $13.79M | $14.77M | $14.64M |
| Gross profit | $7.12M | $5.55M | $2.81M | $3.44M | $5.84M | $4.87M | $3.07M | $3.48M |
| R&D expense | $92,000 | $107,000 | $63,000 | $71,000 | $0 | $0 | $0 | — |
| SG&A expense | $4.60M | $5.02M | $4.87M | $5.39M | $5.97M | $6.08M | $4.63M | $4.34M |
| Operating income | $1.64M | -$262,000 | -$2.38M | -$1.49M | -$810,000 | -$2.69M | -$2.04M | -$2.50M |
| Interest expense | $93,000 | $104,000 | — | — | $67,000 | $175,000 | $115,000 | $95,000 |
| Pretax income | $1.90M | $69,000 | -$1.87M | -$953,000 | -$67,000 | -$2.54M | -$2.01M | -$2.45M |
| Income tax | $495,000 | -$601,000 | $114,000 | $54,000 | $58,000 | -$89,000 | $169,000 | -$2.61M |
| Net income | $1.40M | $670,000 | -$1.98M | -$1.04M | -$2.09M | $6.29M | -$2.29M | -$1.03M |
| EBITDA | $2.36M | $244,000 | -$2.13M | -$1.62M | -$528,000 | -$2.33M | -$1.80M | -$4.38M |
| EPS (basic) | 0.16 | 0.07 | -0.21 | — | -0.22 | 0.65 | -0.23 | — |
| EPS (diluted) | 0.15 | 0.07 | -0.21 | — | -0.22 | 0.65 | -0.23 | — |
| Weighted avg. shares (diluted) | 9.10M | 9.11M | 9.42M | — | 9.38M | 9.75M | 10.08M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $28.71M | $28.07M | $47.82M | $57.61M | $58.04M | $60.48M | $14.27M | $16.11M |
| Receivables | $21.09M | $18.64M | $12.54M | $10.04M | $12.60M | $12.35M | $17.20M | $12.23M |
| Inventory | $10.93M | $10.49M | $7.43M | $8.74M | $7.18M | $6.67M | $10.68M | $5.73M |
| Current assets | $67.10M | $64.72M | $74.31M | $83.02M | $84.88M | $86.91M | $89.65M | $83.07M |
| PP&E, net | $15.88M | $15.69M | $15.47M | $15.76M | $16.10M | $16.24M | $19.21M | $17.59M |
| Goodwill | $4.82M | $4.74M | — | $0 | — | — | — | $0 |
| Intangibles | $9.42M | $10.01M | $2.72M | $2.83M | $2.99M | $3.14M | $6.68M | $3.44M |
| Total assets | $107.87M | $106.32M | $102.61M | $111.94M | $119.89M | $122.58M | $152.54M | $147.25M |
| Current liabilities | $14.91M | $14.94M | $8.55M | $12.36M | $13.26M | $13.08M | $30.37M | $22.35M |
| Long-term debt | — | — | — | — | — | — | — | $0 |
| Total debt | — | — | — | — | — | — | — | $0 |
| Total liabilities | $26.55M | $26.72M | $20.97M | $24.95M | $32.80M | $32.86M | $61.39M | $53.70M |
| Shareholders' equity | $81.32M | $79.60M | $81.64M | $86.99M | $87.09M | $89.72M | $91.16M | $93.55M |
| Net debt | — | — | — | — | — | — | — | -$16.11M |
| Shares outstanding | 9.02M | 9.01M | 9.21M | 9.40M | 9.37M | 9.43M | 11.09M | 10.07M |
| Cash flow statement | ||||||||
| Operating cash flow | $2.27M | -$2.30M | -$5.43M | $266,000 | $1.31M | -$1.40M | -$700,000 | $8.82M |
| Capital expenditure | $1.08M | $754,000 | $422,000 | $462,000 | $616,000 | $144,000 | $318,000 | $383,000 |
| Free cash flow | $1.19M | -$3.05M | -$5.85M | -$196,000 | $695,000 | -$1.54M | -$1.02M | $8.44M |
| Investing cash flow | -$1.14M | -$14.29M | -$422,000 | -$462,000 | -$2.52M | $54.53M | -$570,000 | -$611,000 |
| Financing cash flow | -$482,000 | -$2.12M | -$3.94M | -$240,000 | -$1.23M | -$6.93M | -$566,000 | -$651,000 |
| Depreciation & amortization | $718,000 | $506,000 | $250,000 | -$127,000 | $282,000 | $359,000 | $236,000 | -$1.88M |
| Stock-based compensation | $321,000 | $209,000 | $157,000 | $790,000 | $290,000 | $104,000 | $118,000 | $168,000 |
| Share buybacks | $0 | $2.92M | $3.93M | $262,000 | $831,000 | $7.83M | $215,000 | $299,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.